PDS Biotechnology CompanyFLORHAM PARK, N.J., June 30, 2023 (Globe NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech”), a scientific-stage...
5635c4
PDS Biotechnology CorporationFLORHAM PARK, N.J., Sept. 23, 2022 (Globe NEWSWIRE) -- PDS Biotechnology Company (Nasdaq: PDSB), a clinical-phase immunotherapy corporation...
LOS ANGELES--(Business enterprise WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on July 1, 2022, the Payment Committee...
LOS ANGELES--(Enterprise WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical firm, introduced that on June 3, 2022, the Compensation Committee of...
